Background- Secondary bacterial infections including bacteremia have been implicated as a major cause of morbidity and mortality in COVID-19 patients So, it is important to determine the bacteriological profile of organisms responsible for bacteremia among COVID-19 patients along with their antimicrobial resistance pattern Objectives- To determine the bacteriological profile, antimicrobial resistance pattern and clinical outcome among COVID-19 patients with bacteremia as manifestation of secondary bacterial infection. Study design- Single center, cross sectional study Methods- Blood cultures were obtained from COVID-19 patients with features of bacteremia and sepsis based on Sepsis-3 criteria and serum procalcitonin level. Identification an...
The coronavirus disease-2019 pandemic promote antibiotic resistance in bacteria due to overuse of an...
Background: Bloodstream infections (BSI) caused by highly resistant pathogens in non-ICU COVID-19 de...
Introduction: A considerable proportion of patients hospitalized with coronavirus disease 2019 (COVI...
In addition to the pathogenesis of SARS-CoV-2, bacterial co-infection plays an essential role in the...
Background and Objective: Bacterial infections are among the major complications of many viral respi...
Bacterial co-infection in COVID-19 patients significantly contributes to the worsening of the progno...
In addition to the pathogenesis of SARS-CoV-2, bacterial co-infection plays an essential role in the...
Objective: To identify antimicrobial susceptibility pattern of multidrug resistant bacteria causing ...
Background: The pandemic due to severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) has dr...
Introduction: Secondary bacterial infections have been reported in majority of patients hospitalized...
ABSTRACT Background and Objective: Bacterial co-pathogens are commonly occurs in the viral pulmo...
Background Data on the prevalence of bacterial co-infections among COVID-19 patients are limited, e...
Abstract Background Bloodstream infections (BSIs) are an emerging cause of significant morbidity and...
The global onset of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus infections ha...
While it is reported that COVID-19 patients are more prone to secondary bacterial infections, which ...
The coronavirus disease-2019 pandemic promote antibiotic resistance in bacteria due to overuse of an...
Background: Bloodstream infections (BSI) caused by highly resistant pathogens in non-ICU COVID-19 de...
Introduction: A considerable proportion of patients hospitalized with coronavirus disease 2019 (COVI...
In addition to the pathogenesis of SARS-CoV-2, bacterial co-infection plays an essential role in the...
Background and Objective: Bacterial infections are among the major complications of many viral respi...
Bacterial co-infection in COVID-19 patients significantly contributes to the worsening of the progno...
In addition to the pathogenesis of SARS-CoV-2, bacterial co-infection plays an essential role in the...
Objective: To identify antimicrobial susceptibility pattern of multidrug resistant bacteria causing ...
Background: The pandemic due to severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) has dr...
Introduction: Secondary bacterial infections have been reported in majority of patients hospitalized...
ABSTRACT Background and Objective: Bacterial co-pathogens are commonly occurs in the viral pulmo...
Background Data on the prevalence of bacterial co-infections among COVID-19 patients are limited, e...
Abstract Background Bloodstream infections (BSIs) are an emerging cause of significant morbidity and...
The global onset of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus infections ha...
While it is reported that COVID-19 patients are more prone to secondary bacterial infections, which ...
The coronavirus disease-2019 pandemic promote antibiotic resistance in bacteria due to overuse of an...
Background: Bloodstream infections (BSI) caused by highly resistant pathogens in non-ICU COVID-19 de...
Introduction: A considerable proportion of patients hospitalized with coronavirus disease 2019 (COVI...